Eiger Biopharmaceuticals Inc (EIGR) Insider Trading
- $6,305,913.15
- $9,639,277.27
- Nov. 2, 2023
- Eldon C Mayer III
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 2, 2023 | Major Shareholder | 23,398 | $0.30 | Buy | $7,019.40 | |
| Oct. 31, 2023 | Major Shareholder | 154,841 | $0.24 | Buy | $37,161.84 | |
| March 17, 2023 | VP | 4,395 | $1.07 | Sell | $4,702.65 | |
| Jan. 23, 2023 | Director | 50,000 | $1.43 | Buy | $71,500.00 | |
| Dec. 22, 2022 | Director | 22,500 | $1.17 | Sell | $26,325.00 | |
| Aug. 16, 2022 | Director | 5,000 | $9.81 | Sell | $49,050.00 | |
| March 14, 2022 | VP | 1,657 | $5.60 | Sell | $9,279.20 | |
| March 14, 2022 | CFO | 2,266 | $5.60 | Sell | $12,689.60 | |
| Jan. 7, 2022 | VP | 1,560 | $4.95 | Sell | $7,722.00 | |
| April 9, 2021 | Director | 2,500 | $8.49 | Buy | $21,225.00 | |
| March 15, 2021 | Director | 2,000 | $10.14 | Sell | $20,280.00 | |
| Jan. 8, 2021 | VP | 1,690 | $11.68 | Sell | $19,739.20 | |
| Aug. 12, 2020 | Director | 10,000 | $11.46 | Buy | $114,600.00 | |
| Jan. 24, 2020 | VP | 5,000 | $13.52 | Buy | $67,600.00 | |
| Jan. 10, 2020 | Director | 4,000 | $13.84 | Buy | $55,360.00 | |
| April 22, 2019 | CFO | 1,250 | $11.08 | Buy | $13,850.00 | |
| April 22, 2019 | Insider | 1,000 | $11.03 | Buy | $11,030.00 | |
| April 22, 2019 | Director | 5,000 | $11.05 | Buy | $55,250.00 | |
| Feb. 4, 2019 | Insider | 227 | $14.13 | Buy | $3,207.51 | |
| Dec. 20, 2018 | Director | 5,000 | $9.98 | Buy | $49,900.00 | |
| Dec. 6, 2018 | Director | 5,000 | $11.26 | Buy | $56,300.00 | |
| Nov. 28, 2018 | Director | 6,000 | $10.07 | Buy | $60,420.00 | |
| Nov. 26, 2018 | Director | 7,500 | $9.75 | Buy | $73,125.00 | |
| Oct. 18, 2018 | Major Shareholder | 237,265 | $12.06 | Sell | $2,861,415.90 | |
| April 2, 2018 | Insider | 4,000 | $10.00 | Sell | $40,000.00 | |
| Sept. 1, 2017 | Director | 15,000 | $9.53 | Buy | $142,950.00 | |
| Nov. 18, 2016 | Director | 15,460 | $12.74 | Buy | $196,960.40 | |
| Aug. 18, 2016 | Major Shareholder | 187,500 | $16.00 | Buy | $3,000,000.00 | |
| Aug. 18, 2016 | Insider | 3,125 | $15.70 | Buy | $49,062.50 | |
| June 22, 2016 | CFO | 2,500 | $19.80 | Buy | $49,500.00 | |
| June 13, 2016 | Insider | 1,250 | $22.17 | Buy | $27,712.50 | |
| May 23, 2016 | Insider | 1,245 | $19.80 | Buy | $24,651.00 | |
| April 6, 2015 | CEO | 47,931 | $18.20 | Sell | $872,344.20 | |
| April 2, 2015 | VP | 11,012 | $17.30 | Sell | $190,507.60 | |
| March 9, 2015 | CEO | 47,931 | $24.80 | Sell | $1,188,688.80 | |
| March 6, 2015 | Director | 9,700 | $23.74 | Sell | $230,278.00 | |
| March 6, 2015 | VP | 14,000 | $23.06 | Sell | $322,840.00 | |
| March 2, 2015 | VP | 7,777 | $18.48 | Sell | $143,718.96 | |
| Feb. 9, 2015 | CEO | 47,931 | $15.86 | Sell | $760,185.66 | |
| Feb. 6, 2015 | VP | 14,000 | $16.08 | Sell | $225,120.00 | |
| Feb. 2, 2015 | VP | 7,777 | $16.35 | Sell | $127,153.95 | |
| Jan. 9, 2015 | VP | 10,000 | $18.51 | Sell | $185,100.00 | |
| Jan. 7, 2015 | VP | 20,000 | $17.30 | Sell | $346,000.00 | |
| Jan. 6, 2015 | CEO | 41,302 | $17.51 | Sell | $723,198.02 | |
| Jan. 2, 2015 | VP | 7,777 | $19.88 | Sell | $154,606.76 | |
| Dec. 9, 2014 | VP | 10,000 | $15.00 | Sell | $150,000.00 | |
| Dec. 9, 2014 | CEO | 41,302 | $15.00 | Sell | $619,530.00 | |
| Dec. 5, 2014 | VP | 20,000 | $12.77 | Sell | $255,400.00 | |
| Dec. 1, 2014 | VP | 7,777 | $12.01 | Sell | $93,401.77 | |
| Feb. 4, 2014 | Director | 111,608 | $8.00 | Buy | $892,864.00 |
Insiders are both buying and selling Eiger Biopharmaceuticals Inc stock.
The insider traders at Eiger Biopharmaceuticals Inc are: Eldon C Mayer III, Thomas John Dietz, Krisztina M Zsebo, Rebecque J Laba, Ryan K Takeya, Jeffrey S Glenn, James P Shaffer, Sriram Ryali, Jeffrey J Rudy, Richard A Kayne, Todd Foley, David A Cory, Ventures Fund Vi L.P. Vivo, David Apelian, Enterprise Partners Management, Evan Loh, Fredrik Wiklund, Interwest Partners X. Lp, James H Welch, Joanne Quan, Peter Honig, and Stephana Eilene Patton
The most active insider trader at Eiger Biopharmaceuticals Inc is Eldon C Mayer III with 7 trades.
Interwest Partners X. Lp has sold the most Eiger Biopharmaceuticals Inc stock with a total value of $5,722,831.80.
Ventures Fund Vi L.P. Vivo has bought the most Eiger Biopharmaceuticals Inc stock with a total value of $6,000,000.00.
The most recent insider trade for Eiger Biopharmaceuticals Inc was on Nov. 2, 2023.
The single biggest insider buy for Eiger Biopharmaceuticals Inc was from Ventures Fund Vi L.P. Vivo with a total value of $3,000,000.00 on Aug. 18, 2016.
The single biggest insider sell for Eiger Biopharmaceuticals Inc was from Interwest Partners X. Lp with a total value of $2,861,415.90 on Oct. 18, 2018.